What is a stock summary page? Click here for an overview.
Business Description
Oxurion NV
ISIN : BE0974487192
Compare
Compare
Traded in other countries / regions
OXUR.BelgiumTG40.Germany0G99.UKTBGNF.USA IPO Date
2008-08-07Description
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -3.25 | |||||
| Debt-to-Equity | -0.81 | |||||
| Debt-to-EBITDA | -0.85 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -32.33 | |||||
| Beneish M-Score | -10.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -85.5 | |||||
| 3-Year EBITDA Growth Rate | 74.6 | |||||
| 3-Year EPS without NRI Growth Rate | 78.8 | |||||
| 3-Year FCF Growth Rate | 79.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.85 | |||||
| 9-Day RSI | 32.23 | |||||
| 14-Day RSI | 30.72 | |||||
| 3-1 Month Momentum % | -37.05 | |||||
| 6-1 Month Momentum % | -52.1 | |||||
| 12-1 Month Momentum % | -86.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 17.38 | |||||
| Days Sales Outstanding | 7205.85 | |||||
| Days Payable | 19621.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -343.5 | |||||
| Shareholder Yield % | -569.18 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -25 | |||||
| Operating Margin % | -8615.48 | |||||
| Net Margin % | -13539.29 | |||||
| FCF Margin % | -5517.86 | |||||
| ROA % | -148.85 | |||||
| ROIC % | -41.91 | |||||
| 3-Year ROIIC % | 208.18 | |||||
| ROC (Joel Greenblatt) % | -2781.57 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.42 | |||||
| EV-to-EBIT | -0.86 | |||||
| EV-to-EBITDA | -0.88 | |||||
| EV-to-Revenue | 145.95 | |||||
| EV-to-Forward-Revenue | 18.47 | |||||
| EV-to-FCF | -2.65 | |||||
| Price-to-GF-Value | 0.01 | |||||
| Earnings Yield (Greenblatt) % | -116.28 | |||||
| FCF Yield % | -998.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oxurion NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.084 | ||
| EPS (TTM) (€) | -26.384 | ||
| Beta | 2.93 | ||
| 3-Year Sharpe Ratio | 0.42 | ||
| 3-Year Sortino Ratio | 6.33 | ||
| Volatility % | 71.36 | ||
| 14-Day RSI | 30.72 | ||
| 14-Day ATR (€) | 0.006489 | ||
| 20-Day SMA (€) | 0.100535 | ||
| 12-1 Month Momentum % | -86.78 | ||
| 52-Week Range (€) | 0.075 - 9 | ||
| Shares Outstanding (Mil) | 4.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oxurion NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oxurion NV Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oxurion NV Frequently Asked Questions
What is Oxurion NV(FRA:TG40)'s stock price today?
The current price of FRA:TG40 is €0.08. The 52 week high of FRA:TG40 is €9.00 and 52 week low is €0.08.
When is next earnings date of Oxurion NV(FRA:TG40)?
The next earnings date of Oxurion NV(FRA:TG40) is .
Does Oxurion NV(FRA:TG40) pay dividends? If so, how much?
Oxurion NV(FRA:TG40) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers